These effects were associated with activation of the JNK1 signaling pathway, suggesting that Sfrp5 could play an anti-inflammatory role in obesity-induced inflammation and metabolic dysfunction. The gene discussed is SFRP5; the disease is obesity due to melanocortin 4 receptor deficiency.